Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
· 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
moderate to severe atopic dermatitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
The Effect of Nicorandil on Rheumatoid Arthritis Patients
#1033725
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Record
· ID 868473
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.